Gabapentin Capsule
Product Images NDC 70518-2614

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 70518-2614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Gabapentin 100mg 70518 2614 01)

Gabapentin 100 mg capsule label from RemedyRepack Inc. The label indicates a quantity of 270 capsules and includes the NDC number 70518-2614-01. Manufacturer details show Ascend Labs, LLC with the label instructing refrigeration storage conditions and directing users to the package insert for usage directions.*

FDA Label Image

Gabapentin 100mg 70518 2614 02

Gabapentin 100 mg capsule label by RemedyRepack Inc. The label indicates a quantity of 30 capsules. Manufacturer listed as Ascend Labs, LLC, Montvale, NJ. Includes NDC number 70518-2614-02 and storage instructions, with directions to see the package insert. The label also includes a QR code and cautions to keep the medication out of reach of children.*

FDA Label Image

Gabapentin 100mg 70518 2614 03

Gabapentin 100 mg capsule label by RemedyRepack Inc. The carton or container label displays the product name, strength (100 mg), dosage form (capsule), and quantity (30 capsules). It includes the NDC number 70518-2614-03, repackager information, storage instructions, and a QR code. The label states 'RX ONLY' and notes the manufacturer as Ascend Labs, LLC, Montvale, NJ.*

FDA Label Image

Gabapentin 100mg 70518 2614 04

Gabapentin 100 mg capsule label showing a quantity of 100 capsules. The label includes the NDC 70518-2614-04, manufacturer information (Ascend Labs, LLC, Montvale, NJ), and repackaging details by RemedyRepack Inc. Directions reference the package insert and storage conditions are provided. The label is marked RX ONLY.*

FDA Label Image

Gabapentin 100mg 70518 2614 05

Gabapentin 100 mg capsule label from RemedyRepack Inc. The label includes the NDC number 70518-2614-05, repackaging details, storage instructions, and manufacturer information for Ascend Labs, LLC. The package quantity is 1 capsule, and the label indicates prescription use only (RX ONLY).*

FDA Label Image

Gabapentin 100mg 70518 2614 06

Gabapentin 100 mg oral capsules label showing bottle quantity of 60 capsules. Label includes labeler name RemedyRepack Inc., repackaged from manufacturer Ascend Labs, LLC, Montvale, NJ. It also displays NDC 70518-2614-06, storage instructions, and a QR code.*

FDA Label Image

Gabapentin 100mg 70518 2614 07

Gabapentin 100 mg oral capsules packaging label showing a quantity of 100 capsules. The label indicates it is repackaged by Remedy Repack Inc. The original manufacturer is Ascend Labs, LLC, Montvale, NJ. The NDC number is 70518-2614-07, with storage instructions and a QR code present on the label.*

FDA Label Image

Gabapentin 100mg 70518 2614 08

Gabapentin 100 mg capsule packaging label from RemedyRepack Inc. The label shows the dosage strength as 100 mg and quantity as 1 capsule. It includes the NDC number 70518-2614-08 and manufacturer information for Ascend Labs, LLC in Montvale, NJ. Directions for use and storage instructions are noted, along with a QR code.*

FDA Label Image

Remedy_label (Remedy Label)

Gabapentin 100 mg capsules label showing a quantity of 90. The label includes the NDC number 70518-2614-00 and states the product is repackaged by RemedyRepack Inc. The manufacturer listed is Ascend Labs, LLC, Montvale, NJ. Directions advise to see the package insert and storage instructions are provided. The label indicates the product is for Rx only.*

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

This image shows a mathematical formula used to calculate creatinine clearance (CLCr), involving factors such as age, weight, serum creatinine levels, and an adjustment multiplier for female patients. It appears on a drug information panel likely related to pharmacokinetics or dosing considerations.*

FDA Label Image

Gabapentin Fig1

A line graph showing mean pain scores over eight weeks comparing placebo and Gabapentin, 3600 mg/day. The x-axis represents weeks including a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin shows a decreasing trend in pain scores, whereas placebo remains relatively stable.*

FDA Label Image

Gabapentin Fig2

A line graph depicting mean pain scores over a 7-week period for three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The x-axis represents weeks from baseline to week 7, and the y-axis shows mean pain score ranging from 0 to 10. The graph highlights a 3-week dose titration period followed by a 4-week fixed dose period, with gabapentin groups showing lower pain scores compared to placebo over time.*

FDA Label Image

Gabapentin Fig3

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) groups in two separate studies. Study 1 shows 12% response for placebo and 29% for gabapentin 3600 mg. Study 2 shows 14% response for placebo, 32% for gabapentin 1800 mg, and 34% for gabapentin 2400 mg, with statistical significance indicated.*

FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

A scatter plot chart showing the relationship between daily dose (mg) on the x-axis ranging approximately from 600 to 1800 mg, and difference (%) on the y-axis ranging from 2% to 22%. The data points represent three studies labeled as STUDY a (black squares), STUDY b (gray squares), and STUDY c (white squares). Each study shows data points at different daily doses with corresponding percentage differences.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.